Doxorubicin Plus Sorafenib in Treatment of Advanced Hepatocellular Carcinoma

被引：6
|
作者：
Pazo Cid, Robert A. [1 ]
Lao, Juan [1 ]
Lanzuela, Manuela [1 ]
机构：
[1] Hosp Univ Miguel Servet, Zaragoza, Spain
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2011年 / 305卷 / 08期
关键词：
D O I：
10.1001/jama.2011.159
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：781 / 781
页数：1
相关论文
共 50 条
  • [1] Sorafenib plus doxorubicin in advanced hepatocellular carcinoma patients: hope or hype?
    Shing, Kit
    Kwok, Gerry
    Chiu, Joanne
    Cheung, Tan To
    Yau, Thomas
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (24)
  • [2] Doxorubicin Plus Sorafenib vs Doxorubicin Alone in Patients With Advanced Hepatocellular Carcinoma A Randomized Trial
    Abou-Alfa, Ghassan K.
    Johnson, Philip
    Knox, Jennifer J.
    Capanu, Marinela
    Davidenko, Irina
    Lacava, Juan
    Leung, Thomas
    Gansukh, Bolorsukh
    Saltz, Leonard B.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (19): : 2154 - 2160
  • [3] TACE plus sorafenib for the treatment of advanced hepatocellular carcinoma.
    Palwe, Vijay Sukhdeo
    Nagarkar, Rajnish Vasant
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Doxorubicin and Sorafenib for Treatment of Advanced Hepatocellular Cancer
    Abou-Alfa, Ghassan K.
    Saltz, Leonard B.
    [J]. GASTROENTEROLOGY, 2011, 141 (03) : E19 - E20
  • [5] S-1 plus sorafenib for the treatment of advanced hepatocellular carcinoma
    Huang, Wukui
    You, Lina
    Liu, Dengyao
    Yang, Shufa
    Liu, Mo
    Wang, Hailin
    Wang, Pingju
    Baikere, Pahaerding
    Gu, Peng
    Abulikemu, Abulajiang
    Yuan, Shaoha
    Fan, Xiwen
    [J]. JOURNAL OF BUON, 2016, 21 (06): : 1388 - 1393
  • [6] Sorafenib for the treatment of advanced hepatocellular carcinoma
    Connock, M.
    Round, J.
    Bayliss, S.
    Tubeuf, S.
    Greenheld, W.
    Moore, D.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 17 - 21
  • [7] Doxorubicin and Sorafenib for Treatment of Advanced Hepatocellular Cancer Reply
    Reig, Maria
    Bruix, Jordi
    [J]. GASTROENTEROLOGY, 2011, 141 (03) : E20 - E21
  • [8] Doxorubicin and sorafenib improves survival in patients with advanced hepatocellular carcinoma
    Lisa Hutchinson
    [J]. Nature Reviews Clinical Oncology, 2011, 8 (2) : 61 - 61
  • [9] The Efficacy of Transarterial Chemoembolization plus Apatinib or Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma
    Chen, Lei
    Sun, Tao
    Wu, Linxia
    Zhang, Weihua
    Ren, Yanqiao
    Xiang, Dongqiao
    Liang, Bin
    Zheng, Chuansheng
    [J]. JOURNAL OF ONCOLOGY, 2021, 2021
  • [10] Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma Phase 3 CALGB 80802 Randomized Clinical Trial
    Abou-Alfa, Ghassan K.
    Shi, Qian
    Knox, Jennifer J.
    Kaubisch, Andreas
    Niedzwiecki, Donna
    Posey, James
    Tan, Benjamin R., Jr.
    Kavan, Petr
    Goel, Rakesh
    Lammers, Philip E.
    Bekaii-Saab, Tanios S.
    Tam, Vincent C.
    Rajdev, Lakshmi
    Kelley, Robin K.
    El Dika, Imane
    Zemla, Tyler
    Potaracke, Ryan, I
    Balletti, Jennifer
    El-Khoueiry, Anthony B.
    Harding, James H.
    Suga, Jennifer M.
    Schwartz, Lawrence H.
    Goldberg, Richard M.
    Bertagnolli, Monica M.
    Meyerhardt, Jeffrey
    O'Reilly, Eileen M.
    Venook, Alan P.
    [J]. JAMA ONCOLOGY, 2019, 5 (11) : 1582 - 1588
12345